FONDAZIONE MONDINO CONTRIBUTES TO BREAKTHROUGH IN MOLECULAR MECHANISMS OF ALS
Researchers at Fondazione Mondino IRCCS have played a key role in advancing our understanding of the molecular mechanisms underlying amyotrophic lateral sclerosis (ALS)—a neurodegenerative disease with limited treatment options. Their contributions are part of several high-impact studies revealing genetic and RNA-related processes crucial to disease progression. [...]








